# DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening

> **NCT05290922** · — · UNKNOWN · sponsor: **Lei Li** · enrollment: 7150 (estimated)

## Conditions studied

- Endometrial Cancer
- Cancer Screening
- DNA Methylation
- Testing Accuracy
- Cervical Cytology

## Interventions

- **DIAGNOSTIC_TEST:** DNA methylation testing

## Key facts

- **NCT ID:** NCT05290922
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-12
- **Primary completion:** 2022-09-12
- **Final completion:** 2023-03-12
- **Target enrollment:** 7150 (ESTIMATED)
- **Last updated:** 2022-03-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05290922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05290922, "DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05290922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*